BMC medical research methodology · 2026
Applications of causal and structural equation modeling in epidemiology: a systematic and critical review.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Essetcheou Scholastique Midokpè Merveille, Dovonou Houétchénou Gislain Fortuné, Tahi Souand Peace Gloria, Houetohossou Sèton Calmette Ariane, Salako Valère Kolawolé, Donou Hounsode Marcel Tadogbè, Glèlè Kakaï Romain
Аннотация
BACKGROUND: Structural equation modeling (SEM) and causal modeling (CM) are powerful statistical approaches for identifying complex interrelationships among variables. However, their application in epidemiology remains limited and under-documented, especially in infectious disease research, which requires integrated analytical frameworks for effective control.
METHODS: To examine how SEM and CM have been applied, their methodological characteristics, and reporting practices, a systematic and critical review was conducted following PRISMA guidelines. The search covered studies published between 1987 and 2025 across PubMed, Scopus, Web of Science, ScienceDirect, SpringerLink, Google Scholar, and the Directory of Open Access Journals. After rigorous screening, 458 articles were thoroughly evaluated.
RESULTS: Most studies focused on neuropsychiatric (32.1%) and chronic (30.1%) conditions, with few addressing infectious diseases (24.0%), primarily malaria, tuberculosis, and HIV, particularly in low-income countries where context-specific evidence is urgently needed to inform targeted interventions. SEM studies predominantly used maximum likelihood estimation (57.7%) and large samples ([Formula: see text] observations in 85%) with CB-SEM remaining the dominant approach across all sample size categories. In contrast, CM studies showed substantial variability in sample sizes across approaches, ranging from fewer than 100 to over 200 observations (coefficient of variation [Formula: see text]), with no consistent sample size threshold across methods. Methodological reporting was often incomplete, notably regarding study design (17.4%), measurement validity (15.8%), and model fit criteria (5.2%), reducing transparency and reproducibility.
CONCLUSION: Overall, broader application of SEM and CM to infectious diseases, combined with improved methodological transparency, could substantially strengthen causal inference and guide evidence-based disease control strategies. Moreover, integrating longitudinal study designs would further enhance the robustness and interpretability of causal findings.
METHODS: To examine how SEM and CM have been applied, their methodological characteristics, and reporting practices, a systematic and critical review was conducted following PRISMA guidelines. The search covered studies published between 1987 and 2025 across PubMed, Scopus, Web of Science, ScienceDirect, SpringerLink, Google Scholar, and the Directory of Open Access Journals. After rigorous screening, 458 articles were thoroughly evaluated.
RESULTS: Most studies focused on neuropsychiatric (32.1%) and chronic (30.1%) conditions, with few addressing infectious diseases (24.0%), primarily malaria, tuberculosis, and HIV, particularly in low-income countries where context-specific evidence is urgently needed to inform targeted interventions. SEM studies predominantly used maximum likelihood estimation (57.7%) and large samples ([Formula: see text] observations in 85%) with CB-SEM remaining the dominant approach across all sample size categories. In contrast, CM studies showed substantial variability in sample sizes across approaches, ranging from fewer than 100 to over 200 observations (coefficient of variation [Formula: see text]), with no consistent sample size threshold across methods. Methodological reporting was often incomplete, notably regarding study design (17.4%), measurement validity (15.8%), and model fit criteria (5.2%), reducing transparency and reproducibility.
CONCLUSION: Overall, broader application of SEM and CM to infectious diseases, combined with improved methodological transparency, could substantially strengthen causal inference and guide evidence-based disease control strategies. Moreover, integrating longitudinal study designs would further enhance the robustness and interpretability of causal findings.